General
In laboratory medicine, the quality of tests performed must allow our clinicians to practice good medicine. This raises the questions of exactly what level of quality is required to ensure clinical decision making and how an external quality assurance program objectively assesses the quality of results obtained by laboratories.
The RCPAQAP has used analytical performance goals to assess the quality of results. These goals, called Analytical Performance Specifications (APS), are quality standards to allow participating laboratories to assess their performance and respond accordingly. They have been total error goals based on clinical need and were initially established and maintained by expert advisory groups based on expert opinion and peer-based capability.
There now exists an internationally agreed hierarchy of preferred methods for establishing performance goals. These were developed at a conference organised by World Health Organisation (WHO), International Federation of Clinical Chemistry (IFCC) and International Union of Pure and Applied Chemistry (IUPAC) in Stockholm in 1999. The consensus statement Strategies to Set Global Analytical Quality Specifications in Laboratory Medicine provided a series of approaches arranged in a hierarchy with the aim to apply models higher in the hierarchy in preference to those at lower levels. In summary, these models are:
- Goals-based on clinical outcome
- Goals-based on clinical decision making
- Clinician survey
- Biological inter and intra individual variability
- Goals-based on expert opinion
- Goals-based on peer capability (e.g. from external quality assurance)
- Goals otherwise based on state of the art
The RCPAQAP Chemical Pathology, Haematology and Immunology programs have reviewed the APS based on the Stockholm Hierarchy for all quantitative measurands. While goals based on clinical outcome are rare and clinician surveys uncommon, intra-individual and inter-individual biological variability estimates are available for all common measurands.
The Australasian Association of Clinical Biochemistry and Laboratory Medicine (AACB) established a Working Party on Analytical Performance Specifications which has assisted the RCPAQAP in understanding the use of APSs within the RCPAQAP and developed some principles to allow the review of the APS based on the Stockholm Hierarchy. They have presented QC Updates during the AACB Scientific Conference, as well as at the RCPA Pathology Update and AACB Scientific Education Seminars. At these meetings, the feasibility of applying biological variability as the basis for all APSs has been presented.
Analytical Performance Specifications Based on Biological Variability
Biological variability is the variability in a parameter due to physiological differences within individuals (CVi) and between individuals (CVg). Each individual has random fluctuations around a homeostatic set point, but these homeostatic set points will vary between individuals.
Similarly, analytical goals may relate to monitoring a single patient or making a diagnosis based on the likelihood of belonging to a healthy or diseased group of patients. Logically, the more difficult task is to perceive a change within an individual compared to being able to tell the difference between individuals. The analytical goal for monitoring a patient is that noise added by analytical uncertainty (CVa) should be less than half the daily biological variability of the patient (CVa < ½ CVi). The performance goals for diagnosis are wider and typically expressed as
Total Error (TE) = 0.25 (CVi2 + CVg2)½ + 1.65 x ½ CVi.
Callum Fraser also described a fine-tuning of imprecision and total error goals from minimal, desirable and optimal. External Quality Assessment (EQA) experts have also considered that when stating total error goals for EQA programs, we should be 99% sure when we say that a laboratory has exceeded the performance goals (rather than 95% sure) so 2.33 is used as the multiple for imprecision rather than 1.65.
Monitoring (APS = 2 x CVa) | Diagnosis (APS = TE) | |
Optimal | CVa = ¼ CVi | TE = 0.125 (CVi2 + CVg2)½ + 2.33 x ¼ CVi |
Desirable | CVa = ½ CVi | TE = 0.250 (CVi2 + CVg2)½ + 2.33 x ½ CVi |
Minimal | CVa = ¾ CVi | TE = 0.375 (CVi2 + CVg2)½ + 2.33 x ¾ CVi |
Therefore, the new APS are defined using biological variability principles but only adopted when the majority of participants can achieve the goals. As a general rule, a goal is adopted if over 80% of laboratories can achieve the performance as we also seek to encourage further refinement of methods particularly to achieve the tighter monitoring goals.
Analytical Performance Specification Review Process
The aim is for the APSs for all measurands to be reviewed based on the principles outlined above. Revised APS have been introduced for most of the Chemical Pathology, Haematology and Immunology programs. The review is ongoing and conducted by the specialist parties, the RCPAQAP and other experts when required.
Click on the links below to access Analytical Performance Specifications for RCPAQAP disciplines
Chemical Pathology Analytical Performance Specifications
Haematology Analytical Performance Specifications
References
Badrick T, Biological Variations: Understanding why it is so important. Practical Laboratory Medicine 2021;23, e00199, ISSN 2352-5517.
https://doi.org/10.1016/j.plabm.2020.e00199
(https://www.sciencedirect.com/science/article/pii/S2352551720301621)
Analysing results with less than (<) or greater than (>) values
Participants should test proficiency items in the same manner as patient specimens and this include submission of results and the use of < and > calculations. Previously, these results were excluded from the statistical analysis for some programs and not assessed or displayed on histograms, Youden or Linearity plots. Likewise, where programs had two samples per survey, the result of the accompanying sample would not plot on the Youden.
As a result of feedback from our customers, values above or below the nominated measuring range will be included in the statistical analysis and displayed on the reports. RCPAQAP software will remove the < / >, and the resulting numerical values used to obtain the target median. The survey results will still show as submitted (e.g. <4.0 mmol/l) on the report, but will not be assessed against the related APS.
We will continue to assess if this change adds value to survey reports and welcome your feedback.
Outlier detection process when calculating Mean, Standard Deviation (SD) and coefficient of variation (CV)
The mean, SD and CV are illustrated in survey reports when analysing quantitative results. To calculate these values, a process to eliminate outliers is performed on the assessment categories before the final calculations are performed to determine the mean, SD and CV.
The process to detect outliers uses traditional statistics, where all results outside three standard deviations of the mean value are removed. Once removed, the values are recalculated to determine a revised mean, SD and CV. This process is repeated again before the final mean, SD and CV are calculated. These are illustrated in the reports.
This process is only performed on method category groups with six or more results in the dataset. Once this process is complete and outlier results have been eliminated from statistical calculations, the remainder of the results submitted will be used to calculate the final “All Method” mean, SD and CV.
Significant Figures and Rounding
RCPAQAP reports may contain values with too many significant figures for meaningful result analysis and are condensed by ‘rounding’. This is a simple procedure that reduces the number of significant figures according to established standards.
The number of significant figures considered sufficient will depend on the type of measurand. However, during calculations to perform statistical analysis, no rounding is performed until the final value is calculated.
In a simple example containing five significant figures, 1.1451 becomes 1.15 where three significant figures is considered sufficient. Note that 1.14 would be incorrect rounding, since 1.15 is closer than 1.14.
Quantitative survey results – result flagging
Survey results outside the Analytical Performance Specifications (APS) are highlighted as red or amber in survey reports and listed as high or low in the “Summary of Performance” and “Overall Performance” sections. The colour assists in prioritising result review and are defined below.
Red = Result is outside the APS range of the ‘all result’ target.
Amber = Result is outside the APS range of the ‘all result’ target but within the APS range of the ‘peer group’ target OR Result is within the APS range of the ‘all result’ target but outside the APS range of the ‘peer group’ target.
Supervisor reports adopt this logic and will highlight results according.
Reference
Australian Standard AS2706-2003, ‘Numerical values – rounding and interpretation of limiting values’. (Sydney) Standards Australia, 2nd ed 2003.
Badrick T and Hickman PE. Significant Figures. Clin Biochem Rev Vol 29 (i) 2008 ppS89-S91.